SCCG
Sachem Capital Corp. 8.00% Note
REIT - Mortgage
Market Cap$1.14B
5Y Perf.-3.9%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SCCG vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
WELL
Welltower Inc.
REIT - Healthcare Facilities
Market Cap$149.25B
5Y Perf.+177.9%
SCCG vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SCCG | WELL |
|---|---|---|
| Industry | REIT - Mortgage | REIT - Healthcare Facilities |
| Market Cap | $1.14B | $149.25B |
| Revenue (TTM) | $0.00 | $11.63B |
| Net Income (TTM) | $2M | $1.43B |
| Gross Margin | — | 39.1% |
| Operating Margin | — | 4.4% |
| Forward P/E | 397.8x | 78.4x |
| Total Debt | $0.00 | $21.38B |
| Cash & Equiv. | $11M | $5.03B |
SCCG vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SCCG
WELL
| Stock | Aug 22 | May 26 | Return |
|---|---|---|---|
| Sachem Capital Corp… (SCCG) | 100 | 96.1 | -3.9% |
| Welltower Inc. (WELL) | 100 | 277.9 | +177.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SCCG vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: WELL leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Sachem Capital Corp. 8.00% Note is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
SCCG
Sachem Capital Corp. 8.00% Note
The Real Estate Income Play
SCCG is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.09
- Beta 0.09, yield 0.8%
- Beta 0.09 vs WELL's 0.13
Best for: sleep-well-at-night and defensive
WELL
Welltower Inc.
The Real Estate Income Play
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 223.1% 10Y total return vs SCCG's 24.3%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | WELL | 35.8% FFO/revenue growth vs SCCG's -100.0% |
| Value | WELL | Lower P/E (78.4x vs 397.8x) |
| Stability / Safety | SCCG | Beta 0.09 vs WELL's 0.13 |
| Dividends | WELL | 1.3% yield, 2-year raise streak, vs SCCG's 0.8% |
| Momentum (1Y) | WELL | +42.7% vs SCCG's +28.8% |
| Efficiency (ROA) | WELL | 2.3% ROA vs SCCG's 0.4% |
SCCG vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
SCCG vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLWELLLAGGINGSCCG
SCCGSachem Capital Corp. …
1leads
WELLWelltower Inc.
4leads
6 Total Categories
CATEGORYLEADERvs SCCGMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
WELL4/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
WELL3/5
Total Returns1Y, 3Y, 5Y total returns with dividends
WELL6/6
Risk & VolatilityBeta, volatility, and downside exposure
SCCG2/2
Analyst OutlookRatings, price targets, and dividends
WELL2/2
Income & Cash Flow (Last 12 Months)
Evenly matched — SCCG and WELL each lead in 1 of 2 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL and SCCG operate at a comparable scale, with $11.6B and $0 in trailing revenue. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SCCGSachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| RevenueTrailing 12 months | $0 | $11.6B |
| EBITDAEarnings before interest/tax | $22M | $2.8B |
| Net IncomeAfter-tax profit | $2M | $1.4B |
| Free Cash FlowCash after capex | $3M | $2.5B |
| Gross MarginGross profit ÷ Revenue | — | +39.1% |
| Operating MarginEBIT ÷ Revenue | — | +4.4% |
| Net MarginNet income ÷ Revenue | — | +12.3% |
| FCF MarginFCF ÷ Revenue | — | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.1% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +103.4% | +22.5% |
Evenly matched — SCCG and WELL each lead in 1 of 2 comparable metrics.
Valuation Metrics
WELL leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 153.3x trailing earnings, WELL trades at a 74% valuation discount to SCCG's 596.8x P/E.
| Metric | SCCGSachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| Market CapShares × price | $1.1B | $149.2B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $165.6B |
| Trailing P/EPrice ÷ TTM EPS | 596.75x | 153.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 397.83x | 78.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.40x |
| Price / SalesMarket cap ÷ Revenue | — | 13.99x |
| Price / BookPrice ÷ Book value/share | 6.40x | 3.35x |
| Price / FCFMarket cap ÷ FCF | 455.30x | 52.41x |
WELL leads this category, winning 4 of 4 comparable metrics.
Profitability & Efficiency
WELL leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $1 for SCCG. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs SCCG's 5/9, reflecting strong financial health.
| Metric | SCCGSachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +1.0% | +3.5% |
| ROA (TTM)Return on assets | +0.4% | +2.3% |
| ROICReturn on invested capital | — | +0.5% |
| ROCEReturn on capital employed | — | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | — | 0.49x |
| Net DebtTotal debt minus cash | -$11M | $16.3B |
| Cash & Equiv.Liquid assets | $11M | $5.0B |
| Total DebtShort + long-term debt | $0 | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x |
WELL leads this category, winning 3 of 5 comparable metrics.
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $12,430 for SCCG. Over the past 12 months, WELL leads with a +42.7% total return vs SCCG's +28.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs SCCG's 10.9% — a key indicator of consistent wealth creation.
| Metric | SCCGSachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| YTD ReturnYear-to-date | +3.6% | +14.3% |
| 1-Year ReturnPast 12 months | +28.8% | +42.7% |
| 3-Year ReturnCumulative with dividends | +36.4% | +189.5% |
| 5-Year ReturnCumulative with dividends | +24.3% | +202.3% |
| 10-Year ReturnCumulative with dividends | +24.3% | +223.1% |
| CAGR (3Y)Annualised 3-year return | +10.9% | +42.5% |
WELL leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
SCCG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SCCG is the less volatile stock with a 0.09 beta — it tends to amplify market swings less than WELL's 0.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | SCCGSachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.09x | 0.13x |
| 52-Week HighHighest price in past year | $24.55 | $219.59 |
| 52-Week LowLowest price in past year | $11.58 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +97.2% | +97.0% |
| RSI (14)Momentum oscillator 0–100 | 59.4 | 60.2 |
| Avg Volume (50D)Average daily shares traded | 4K | 2.6M |
SCCG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
WELL leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, WELL offers the higher dividend yield at 1.30% vs SCCG's 0.85%.
| Metric | SCCGSachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $226.50 |
| # AnalystsCovering analysts | — | 34 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.20 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
WELL leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
WELL leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). SCCG leads in 1 (Risk & Volatility). 1 tied.
Best OverallWelltower Inc. (WELL)Leads 4 of 6 categories
Loading custom metrics...
SCCG vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SCCG or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -100. 0% for Sachem Capital Corp. 8. 00% Note (SCCG). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SCCG or WELL?
On trailing P/E, Welltower Inc.
(WELL) is the cheapest at 153. 3x versus Sachem Capital Corp. 8. 00% Note at 596. 8x. On forward P/E, Welltower Inc. is actually cheaper at 78. 4x.
03Which is the better long-term investment — SCCG or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to +24. 3% for Sachem Capital Corp. 8. 00% Note (SCCG). Over 10 years, the gap is even starker: WELL returned +223. 1% versus SCCG's +24. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SCCG or WELL?
By beta (market sensitivity over 5 years), Sachem Capital Corp.
8. 00% Note (SCCG) is the lower-risk stock at 0. 09β versus Welltower Inc. 's 0. 13β — meaning WELL is approximately 42% more volatile than SCCG relative to the S&P 500.
05Which is growing faster — SCCG or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -100. 0% for Sachem Capital Corp. 8. 00% Note (SCCG). On earnings-per-share growth, the picture is similar: Sachem Capital Corp. 8. 00% Note grew EPS 104. 3% year-over-year, compared to -11. 5% for Welltower Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SCCG or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus 0. 0% for Sachem Capital Corp. 8. 00% Note — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus 0. 0% for SCCG. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SCCG or WELL more undervalued right now?
On forward earnings alone, Welltower Inc.
(WELL) trades at 78. 4x forward P/E versus 397. 8x for Sachem Capital Corp. 8. 00% Note — 319. 4x cheaper on a one-year earnings basis.
08Which pays a better dividend — SCCG or WELL?
All stocks in this comparison pay dividends.
Welltower Inc. (WELL) offers the highest yield at 1. 3%, versus 0. 8% for Sachem Capital Corp. 8. 00% Note (SCCG).
09Is SCCG or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, SCCG: +24. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SCCG and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SCCG is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(SCCG: -205.3% · WELL: 40.3%)P/E Ratio<
x
(SCCG: 596.8x · WELL: 153.3x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.